Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
53
CRZBY Quote, Financials, Valuation and Earnings
Last price:
$15.82
Seasonality move
:
0.27%
Day range:
$15.76 - $16.07
52-week range:
$10.98 - $18.59
Dividend yield:
3.73%
P/E ratio:
8.22x
P/S ratio:
1.47x
P/B ratio:
0.50x
Volume:
20.3K
Avg. volume:
19.5K
1-year change:
38.77%
Market cap:
$18.7B
Revenue:
$12.8B
EPS (TTM):
$1.92
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9B | $10B | $11.4B | $11B | $12.8B | |
| Revenue Growth (YoY) | -2.18% | 1.03% | 14.1% | -3.98% | 16.71% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6B | $1.6B | $1.6B | $1.3B | $1.4B | |
| Other Inc / (Exp) | $122M | $207.8M | $692.2M | $74.9M | -$108.3M | |
| Operating Expenses | $7.8B | $8.3B | $8.7B | $7.8B | $8.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | -$3B | $124.2M | $2.1B | $3.7B | |
| Earnings of Discontinued Ops. | -$20.2M | $34.3M | -- | -- | -- | |
| Income Tax Expense | $471.3M | $301.5M | -$293.4M | $645.4M | $1.3B | |
| Net Income to Company | $766.9M | -$3.3B | $418.8M | $1.5B | $2.4B | |
| Minority Interest in Earnings | -$111.9M | -$10.3M | $91.1M | $44.3M | $10.8M | |
| Net Income to Common Excl Extra Items | $654.9M | -$3.3B | $508.8M | $1.5B | $2.4B | |
| Basic EPS (Cont. Ops) | $0.53 | -$2.66 | $0.27 | $1.04 | $1.76 | |
| Diluted EPS (Cont. Ops) | $0.53 | -$2.66 | $0.27 | $1.04 | $1.76 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.4B | -$18.3M | $3B | $6.2B | $14.4B | |
| Revenue (Reported) | $9.9B | $10B | $11.4B | $11B | $12.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.4B | -$18.3M | $3B | $6.2B | $14.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.4B | $1.8B | $2.3B | $2.3B | |
| Revenue Growth (YoY) | 2.57% | -4.29% | -25.35% | 28.12% | 2.95% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$16.4M | $535.3M | $103.8M | -$149.2M | -$172.7M | |
| Operating Expenses | $2B | $2B | $1.4B | $975.6M | $957.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$37.4M | $466.9M | $269M | $1.2B | $972.2M | |
| Earnings of Discontinued Ops. | -$12.9M | -- | -- | -- | -- | |
| Income Tax Expense | $14M | -$7.1M | $229.7M | $441M | $215.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$17.5M | $1.2M | $156.1M | -$21.8M | -$50.6M | |
| Net Income to Common Excl Extra Items | -$80.7M | $475.2M | $196.4M | $744.7M | $705M | |
| Basic EPS (Cont. Ops) | -$0.06 | $0.51 | $0.16 | $0.60 | $0.59 | |
| Diluted EPS (Cont. Ops) | -$0.06 | $0.51 | $0.16 | $0.60 | $0.59 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $665.4M | $1.2B | $1.2B | $4.1B | $4.6B | |
| Revenue (Reported) | $2.5B | $2.4B | $1.8B | $2.3B | $2.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $665.4M | $1.2B | $1.2B | $4.1B | $4.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.7B | $11.1B | $10.8B | $12.1B | $13B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$114.8M | $1.2B | $255.3M | -$332.3M | -$64M | |
| Operating Expenses | $7.8B | $9.1B | $7.3B | $7.8B | $8.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14.4M | -$3B | $1.8B | $3.6B | $3.7B | |
| Earnings of Discontinued Ops. | $12.4M | -$11.9M | -- | -- | -- | |
| Income Tax Expense | $238.8M | $178.4M | $466.1M | $1.1B | $1.1B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$55.1M | -$4M | $216M | -$72.3M | -$86.3M | |
| Net Income to Common Excl Extra Items | -$265.8M | -$3.2B | $1.5B | $2.5B | $2.5B | |
| Basic EPS (Cont. Ops) | -$0.20 | -$2.63 | $0.92 | $1.80 | $1.92 | |
| Diluted EPS (Cont. Ops) | -$0.20 | -$2.63 | $0.92 | $1.80 | $1.92 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.1B | -$144.1M | $4.8B | $12.7B | $17.7B | |
| Revenue (Reported) | $9.7B | $11.1B | $10.8B | $12.1B | $13B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.1B | -$144.1M | $4.8B | $12.7B | $17.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.2B | $8.2B | $7.6B | $8.7B | $9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$155.8M | $790.7M | $348M | -$85.9M | -$42.5M | |
| Operating Expenses | $5.8B | $6.6B | $5.2B | $5.2B | $5.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$118.4M | -$22.4M | $1.6B | $3.1B | $3.1B | |
| Earnings of Discontinued Ops. | $42.3M | -- | -- | -- | -- | |
| Income Tax Expense | $42.8M | -$58.9M | $693.7M | $1.1B | $876.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$40.7M | -$36.2M | $93.6M | -$15M | -$112.1M | |
| Net Income to Common Excl Extra Items | -$159.5M | $297.2K | $1B | $2B | $2.1B | |
| Basic EPS (Cont. Ops) | -$0.12 | -$0.01 | $0.66 | $1.42 | $1.58 | |
| Diluted EPS (Cont. Ops) | -$0.12 | -$0.01 | $0.66 | $1.42 | $1.58 | |
| Weighted Average Basic Share | $3.8B | $3.8B | $3.7B | $3.7B | $3.6B | |
| Weighted Average Diluted Share | $3.8B | $3.8B | $3.7B | $3.7B | $3.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.1B | $2.1B | $4B | $10.5B | $13.8B | |
| Revenue (Reported) | $7.2B | $8.2B | $7.6B | $8.7B | $9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.1B | $2.1B | $4B | $10.5B | $13.8B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $51.7B | $99.9B | $68.2B | $92.9B | $113.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $99.4B | $160.7B | $103B | $119.1B | $135.5B | |
| Property Plant And Equipment | $3.9B | $3.9B | $3.3B | $2.6B | $2.6B | |
| Long-Term Investments | $127.4B | $165.6B | $131.9B | $103.9B | $111.3B | |
| Goodwill | $1.7B | -- | -- | -- | -- | |
| Other Intangibles | $1.7B | $1.7B | $1.4B | $1.4B | $1.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $519.1B | $623.1B | $529.2B | $512B | $571.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $570.2M | $619.9M | $688.4M | $972.7M | $652.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $485B | $588B | $495.4B | $478.8B | $535.2B | |
| Common Stock | $1.4B | $1.5B | $1.4B | $1.3B | $1.4B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $32.7B | $33.8B | $32.7B | $32.2B | $35.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.5B | $1.4B | $1.1B | $952.3M | $1.1B | |
| Total Equity | $34.2B | $35.1B | $33.8B | $33.2B | $36.5B | |
| Total Liabilities and Equity | $519.1B | $623.1B | $529.2B | $512B | $571.7B | |
| Cash and Short Terms | $51.7B | $99.9B | $68.2B | $92.9B | $113.5B | |
| Total Debt | $50.7B | $56.7B | $49.6B | $46.9B | $53.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $106B | $119.8B | $115.6B | $92.7B | $106.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $163.8B | $121.7B | $114.2B | $90.5B | $106.4B | |
| Property Plant And Equipment | $3.7B | $3.5B | $2.5B | $2.4B | $2.5B | |
| Long-Term Investments | $160.5B | $486.4B | $403.8B | $421.9B | $489.2B | |
| Goodwill | $1.8B | -- | -- | -- | -- | |
| Other Intangibles | $1.7B | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $639.1B | $627.8B | $534.1B | $539.7B | $631.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $446.1M | $646.1M | $573M | $598.1M | $568.5M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $601.5B | $593.3B | $504.1B | $505.1B | $592.6B | |
| Common Stock | $1.5B | $1.5B | $1.2B | $1.3B | $1.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.4B | $1.3B | $765.7M | $1B | $1.3B | |
| Total Equity | $37.5B | $34.5B | $30B | $34.6B | $38.9B | |
| Total Liabilities and Equity | $639.1B | $627.8B | $534.1B | $539.7B | $631.4B | |
| Cash and Short Terms | $106B | $119.8B | $115.6B | $92.7B | $106.4B | |
| Total Debt | $55.7B | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $766.9M | -$3.3B | $418.8M | $1.5B | $2.4B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$12.1B | $38.5B | -$28.7B | $27.3B | $21.7B | |
| Capital Expenditures | $782.5M | $1B | $1.2B | $711.9M | $1.1B | |
| Cash Acquisitions | -$223.9M | -$496.8M | -$129M | -$97M | $21.7M | |
| Cash From Investing | -$944.9M | -$1.4B | -$951.3M | -$751.9M | -$996M | |
| Dividends Paid (Ex Special Dividend) | -$279.9M | -- | -- | -- | -$270.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$132.1M | |
| Other Financing Activities | -$1.1M | $1.1M | -$1.2M | -- | -- | |
| Cash From Financing | -$1.3B | $2.5B | -$1.4B | $187.7M | -$1.2B | |
| Beginning Cash (CF) | $60.4B | $47B | $89.5B | $52.2B | $81.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$14.3B | $39.6B | -$31.1B | $26.7B | $19.6B | |
| Ending Cash (CF) | $46.1B | $86.3B | $58.6B | $79.3B | $100.8B | |
| Levered Free Cash Flow | -$12.9B | $37.4B | -$29.9B | $26.6B | $20.7B | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $19B | -$1.8B | -$3.7B | -$12.9B | -$9.9B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.3B | -$324.9M | -$314.7M | -$186.5M | -$1.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.2B | $101.1M | -$1.3B | -$129M | $606.1M | |
| Beginning Cash (CF) | $29.2B | $66.6B | $67.3B | $59B | $97.9B | |
| Foreign Exchange Rate Adjustment | $223M | $52.1M | $25.2M | -$16.2M | -$7.9M | |
| Additions / Reductions | $10.5B | -$2B | -$5.3B | -$13.3B | -$10.4B | |
| Ending Cash (CF) | $40.1B | $63.1B | $63.7B | $46.1B | $86.3B | |
| Levered Free Cash Flow | $19B | -$1.8B | -$3.7B | -$12.9B | -$9.9B | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8B | $23.1B | -$474.7M | -$12.1B | $38.5B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$23.2M | -$514.2M | -$658.9M | -$944.9M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $76.4M | -$309.2M | -$1.1B | -$1.3B | $2.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.1B | $22.3B | -$2.3B | -$14.3B | $39.6B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $8B | $23.1B | -$474.7M | -$12.1B | $38.5B | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CRZBY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRZBY
Sector
P/E ratio
8.22x
11.99x
PEG ratio
1.17x
0.36x
P/B ratio
0.50x
1.05x
Price / LTM sales
1.47x
2.55x
Growth Metrics
CRZBY
Sector
Revenue growth
2.95%
6.08%
Earnings growth
-0.82%
6.45%
Revenue (5-year growth)
4.79%
5.85%
Earnings forecast
--
$0.56
Profitability
CRZBY
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
4.33%
5.27%
Return on assets
0.43%
0.98%
Return on equity
6.94%
9.43%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
13
Estimated Next Earnings Date
Feb
5
Balance Sheet
CRZBY
Sector
Total cash
$106.4B
$615.3M
Short term investments
--
$408.4M
Total assets
$571.7B
$4.5B
Long term debt
--
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
